ArticleBiomedicines2021

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines.

Bashir Lawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.